Andaman7
Andaman7 (A7 Software SA) is a Belgian digital health company offering a patient-controlled mobile Personal Health Record platform with ePRO, RWE, and decentralized clinical trial capabilities. It serves pharmaceutical companies, hospitals, CROs, and individual patients, monetizing through B2B contracts and white-label licensing while keeping the consumer app free.
- Company typePrivate
- Founded2014
- HeadquartersBoncelles, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Andaman7 does
Andaman7 (legal entity A7 Software SA) is a Belgian digital health company founded in 2014, headquartered in Boncelles (Liège), Belgium, with a stated US presence in Redwood City, California. The company operates a patient-controlled mobile Personal Health Record (PHR) platform combined with electronic Patient Reported Outcomes (ePRO) and Real World Evidence (RWE) capabilities, marketed as a single solution for patients, clinicians, and life-science researchers. The platform is built on a distributed architecture in which health data is stored only on the patient's smartphone or tablet and shared peer-to-peer through encrypted channels; Andaman7, the company, has no access to the data. FHIR-based interoperability enables connectivity to approximately 85% of US hospital EHR systems, and patient-mediated access rights are used to retrieve data from 7,000+ US hospitals and care facilities covering roughly 80% of the US population.
The core product is the Andaman7 mobile app (iOS/Android), free for individual users, supporting data collection from hospitals, labs, connected devices, and manual entry alongside configurable questionnaires for clinical studies. The v5 release in March 2024 added an AI module that performs medical-jargon simplification, document summarization, and translation on text extracted from PDFs and image scans. Revenue is generated from B2B contracts with life-science companies (pharma, biotech, CROs, medical-device manufacturers) for clinical trials, RWE studies, and PRO data collection; from hospital and care-actor B2B services (remote monitoring, bidirectional EHR exchange); and from white-label / private-label licensing of the full platform. Named customers include CHU Liège, Laboratoires Réunis, Janssen France, and Ethias, plus NDA-protected engagements with a Top-5 global pharma, a Top-10 global pharma group, and a major US e-health operator (the last valued at approximately USD 500,000). The company holds GDPR, HIPAA, FDA, EMA, GMP, GCP, and Dekra certifications.
The business is led by founder/CEO Vincent Keunen, a cancer survivor and former medical-IT engineer behind Belgium's meXi, Medibridge, and Idewe systems used by approximately 1M workers, and co-founder/COO Philippe Lemmens. Disclosed funding totals approximately USD 2.63M across three rounds in 2014, 2015, and 2017, and the founder has publicly indicated the company is seeking a large strategic investor. Headcount is reported at 11–50 employees.
Andaman7 firmographics
Firmographics- Name
- Andaman7
- Legal name
- A7 Software SA
- Website
- https://andaman7.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Andaman7 (A7 Software SA) is a Belgian digital health company offering a patient-controlled mobile Personal Health Record platform with ePRO, RWE, and decentralized clinical trial capabilities. It serves pharmaceutical companies, hospitals, CROs, and individual patients, monetizing through B2B contracts and white-label licensing while keeping the consumer app free.
- Ownership category
- akta.pro rank
Andaman7 industry classification
Industry- Product category
- Healthcare Data Platform (Personal Health Records & ePRO)
- NAICS
- Software Publishers (5132), Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK)
Keywords
Where Andaman7 is headquartered
LocationHeadquarters
- HQ city
- Boncelles
- HQ country
- Belgium
- HQ region
- Europe
Offices3 records
Markets served
Andaman7 business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Freemium consumer app: Andaman7 is and always will be free for individual users (patients, doctors, nurses, caregivers). Used as a social project to build the patient user base and data network.
- B2B contracts from life sciences (pharma, biotech, CRO, medical device): Financial contributions from pharmaceutical companies and medical device manufacturers in exchange for access to PRO, RWE, clinical trial questionnaires, and patient-mediated research workflows. Reference deal: a half-million-dollar contract signed with a major US e-health operator for a clinical study with strong patient involvement.
- Hospital & care-actor B2B services: Revenue from hospitals and care facilities for remote patient monitoring, home-care, bidirectional data exchange with patient PHRs, and PRO data collection.
- White-label / private-label licensing: Full Andaman7 platform offered as a white-label or private-label solution to other healthcare players (insurers, telemedicine providers, hospitals) to integrate under their own brand.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free for individual users (patients, doctors, nurses, caregivers) |
Go-to-market motion5 records
Distribution channels6 records
Marketing channels7 records
Andaman7 product offering
Product offeringCore offering
Andaman7 builds a distributed, patient-controlled Personal Health Record (PHR) mobile platform that consolidates health data from hospitals, labs, GPs, connected devices, and manual entry onto the patient's smartphone. It adds an ePRO module for clinical trials and Real World Evidence (RWE) studies, an in-app questionnaire engine, an AI module for document simplification/summarization/translation (v5), and offers the full stack as a white-label platform to life-science companies, hospitals, insurers, and telemedicine providers. The app is free for individual users; revenue comes from B2B contracts, subscriptions, and white-label licensing.
Differentiator
Problem solved
Functional benefit
Products and services
- Andaman7 Mobile App (iOS / Android) — Personal Health Record Free-for-individual-users mobile Personal Health Record application that lets patients collect, store, and manage their own health data on their smartphone (data stays on-device, not in the cloud). Available on iOS App Store and Google Play in 20+ languages; used by patients, doctors, nurses, and caregivers.
- Andaman7 White-Label / Private-Label Platform The complete Andaman7 platform — PHR, ePRO, questionnaires, AI, and integrations — offered as a white-label / private-label solution to healthcare organizations so they can deploy a branded PHR under their own name for research projects, telemedicine services, or insured-population programs.
- Andaman7 ePRO / Patient-Reported Outcomes Module ePRO module enabling patients to report outcomes (PROs) from their smartphone for clinical trials and Real World Evidence (RWE) studies. Integrates with hospital CIO systems and CRO EDC systems with pseudonymous data flow to sponsors/manufacturers and identifiable data to hospitals; supports decentralized and siteless trial designs.
- Andaman7 Questionnaires / Assessment Tools Module supporting in-app health questionnaires with multiple question types (free text, date picker, time selector, single/multi-choice, pointer/scale, photo, file upload, numeric, auto-completion). Used for clinical-trial PROs, pre/post-hospitalization follow-up, and remote monitoring workflows; questionnaires can be sent by healthcare providers and answered by patients inside Andaman7.
- Andaman7 AI — Document Simplification, Summarization, and Translation AI module bundled with Andaman7 v5 that extracts text from documents (including photos and scans of paper records), then simplifies medical jargon, summarizes lengthy reports, and translates documents between languages. Available via the "Enable Andaman7 AI" service in the app's Services tab and applied to every document in the user's record.
Quantifiable outcome
- 92% accuracy of patient-recorded medication data
- +4 more outcomes
Companies that use Andaman7
Customer profileNamed customers7 records
Segments6 records
Ideal customer profiles3 records
Andaman7 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability6 records
Feature8 records
Andaman7 partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered minor, flagship and core.
- EUCoLabminorForum of collaborative-economy companies (Airbnb, Uber, Intuit, etc.). Andaman7 was the first EUCoLab member in the health sector and signed an open letter to Commissioner Bienkowska supporting the EU collaborative-economy agenda.
- FiWare FICHe (European accelerator)minorEU-funded FiWare-based accelerator for innovative eHealth apps. Andaman7 was accepted in January 2015 to accelerate go-to-market.
- CHU Liège (University Hospital of Liège)flagshipFlagship hospital partner. Co-developed a bridge between the hospital's EHR (CIO) and Andaman7; 3,000 patients automatically receive hospital data. Winner of the 2018 Patient Numérique Innovation Award with Andaman7. CHU Liège also part of the InteropEHRate EU consortium.
- InteropEHRate (EU consortium)flagshipAndaman7 is part of the EU InteropEHRate consortium (15 European partners) for bottom-up, patient-centered, decentralized EHR interoperability. EU-funded project with a €7M budget, launched Jan 2019 for 42 months. Partners include Engineering, CHU de Liège, Fraunhofer ISST, University of Trento and others.
- EORTC (European Organisation for Research and Treatment of Cancer)coreEcosystem partner in cancer research. Andaman7 engages with EORTC on survivorship-related e-health topics and patient-reported outcomes.
- EIT HealthcoreEuropean health-innovation network (EU knowledge & innovation community). Listed as partner on Andaman7's homepage.
- BioWincoreBelgian health competitiveness cluster. Listed as partner on Andaman7's homepage, providing cluster-level ecosystem support in Wallonia.
- Johnson & Johnson JLABScoreJLABS (J&J Innovation) listed as partner on Andaman7's homepage — access to J&J's life-science innovation network.
- Doctor AnytimeminorBelgian health-services platform. Listed as partner on Andaman7's homepage, helping distribute Andaman7 to patients and professionals.
- AlloLouiseminorBelgian health/patient-services platform. Listed as partner on Andaman7's homepage.
- DataVaultscoreEU H2020 project (datavaults.eu) on personal data management; listed on Andaman7's homepage as a partner for data-vault and personal-data-monetization research.
- Laboratoires RéunisflagshipIntegration partner: Luxembourg medical-biology lab with 50+ years' expertise, 100+ centers and 250+ collaborators in LU/FR/DE/BE/MA. Patients automatically receive structured lab-test results directly in their Andaman7 PHR instead of static PDFs.
- Janssen France (Johnson & Johnson)flagshipClinical study partner: Andaman7 built a solution for Janssen France to digitize quality-of-life data collection, replace paper questionnaires with a PHR + IoT devices + widget, reducing drop-out and improving data quality.
- AwellcoreCo-development partner for the ScarPath digital care pathway project (burn-scar follow-up), together with Oscare (UA/Movant). Awarded 'Most Patient Benefit' (beHealth Hackathon) and the King Baudouin Foundation Award.
- Oscare / University of Antwerp (Movant)coreClinical co-development partners for ScarPath: Ulrike Van Daele and Jill Meirte of Oscare/UAntwerp drove the care pathway design with Awell and Andaman7.
- EthiascoreBelgian insurer. Andaman7 listed on Ethias' certified health-app kiosk since Sept 2020, organized into 'Santé adulte', 'Santé enfant', 'Aide et bien-être'. Ethias performs no data exploitation.
Scale indicators8 records
Recent moves8 records
Expansion highlights6 records
Andaman7 competitors and assessment
Company assessmentEmerging players
- THREAD Research: Decentralized clinical trial technology platform supporting eCOA, ePRO, and remote visits. Competes for DCT/RWE contracts with pharma and biotech sponsors.
- Curebase: Decentralized clinical trial platform with virtual site capabilities and ePRO. Emerging competitor focused on DCT execution for biotech and mid-sized pharma.
- ObvioHealth: Virtual/decentralized clinical trial vendor offering ePRO, telehealth, and remote monitoring. Comparable in serving the same pharma/DCT use cases with a similar digital-first approach.
Broad incumbents
- Epic Systems (MyChart): Largest US EHR vendor; MyChart is the dominant tethered patient portal in US hospitals. Adjacent incumbent that Andaman7 complements (rather than replaces) via patient-mediated FHIR access.
- Veeva Systems: Enterprise cloud platform for life sciences, including Vault EDC and Vault ePRO for clinical trials. Broad incumbent with deep pharma relationships; competes in the same clinical operations buying center as Andaman7.
- IQVIA (eCOA/ePRO): Largest CRO and clinical technology provider with an eCOA/ePRO franchise. Competes for pharma DCT and RWE engagements; broad incumbent across the clinical trial value chain.
Direct peers
- Medable: Leading decentralized clinical trial and ePRO platform serving pharma and CROs. Direct competitor in DCT/ePRO; differs by lacking a full patient-controlled PHR layer that Andaman7 offers.
- Castor EDC: Cloud-based electronic data capture and ePRO platform for clinical trials. Competes head-to-head with Andaman7 in DCT/eCOA and remote data capture for pharma and academic sponsors.
- Science 37 (Trialbee): Decentralized clinical trial operator acquired by Trialbee. Direct DCT competitor in patient recruitment and siteless trial delivery for pharma sponsors.
- PatientsKnowBest: UK-based patient-controlled personal health record platform integrated with NHS and hospital EHRs. Closest functional peer to Andaman7's distributed, patient-mediated PHR architecture.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Andaman7 social profiles
Digital presenceAndaman7 compliance and trust
Trust signalCompliance4 records
Andaman7 financial estimates
Financial estimateRevenue estimate
Valuation estimate
Andaman7 leadership team
Management profileNumber of profiles
Profiles3 records
Andaman7 funding detail
Funding detailFunding overview
Funding rounds3 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Andaman7 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Andaman7
What does Andaman7 do?
Andaman7 builds a distributed, patient-controlled Personal Health Record (PHR) mobile platform that consolidates health data from hospitals, labs, GPs, connected devices, and manual entry onto the patient's smartphone. It adds an ePRO module for clinical trials and Real World Evidence (RWE) studies, an in-app questionnaire engine, an AI module for document simplification/summarization/translation (v5), and offers the full stack as a white-label platform to life-science companies, hospitals, insurers, and telemedicine providers. The app is free for individual users; revenue comes from B2B contracts, subscriptions, and white-label licensing.
Is Andaman7 a public or private company?
Andaman7 is a private company. It is classified as venture growth investor backed and is currently operating.
When was Andaman7 founded?
Andaman7 was founded in 2014. It employs 11 to 50 people.
Where is Andaman7 based?
Andaman7 is headquartered in Boncelles, Belgium, in the Europe region.
How does Andaman7 make money?
Four revenue lines are on record. Freemium consumer app is the primary driver. The others are B2B contracts from life sciences (pharma, biotech, CRO, medical device), hospital & care-actor B2B services and white-label / private-label licensing.
Who are Andaman7's main competitors?
Emerging players on record are THREAD Research, Curebase and ObvioHealth. Broad incumbents are Epic Systems (MyChart), Veeva Systems and IQVIA (eCOA/ePRO). Direct peers are Medable, Castor EDC, Science 37 (Trialbee) and PatientsKnowBest.
Does Andaman7 have an API?
Yes. Andaman7 exposes a "No protocol API" described in the technology series, enabling partners and other companies to contribute services to Andaman7 users. The platform also supports integration with hospital CIO systems (e.g., CHU Liège bridge) and with EDC (Electronic Data Capture) systems used by CROs for clinical trials. Available to partners and research integrators rather than as a fully public developer API.
What industry is Andaman7 in?
Andaman7's product category is Healthcare Data Platform (Personal Health Records & ePRO). Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAAAN, EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps. Its NAICS code is 5132 and its SIC code is 7372.